Capsida has yet to disclose the exact cause of death. The patient had received the gene therapy CAP-002 for a type of ...

Capsida is investigating the root cause of the death, which occurred in the first patient treated in a trial of the company’s ...

In the last few years, Gene and Cell Therapy research has emerged as one of the most promising technologies for treating ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Gene Therapy On Neurological Diseases Market Through 2025? Rapid expansion has been ...

Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m, aimed at propelling its gene therapy ...

Sanofi said its gene therapy to treat neovascular age-related macular degeneration was approved for fast-track development in the U.S. The biopharmaceutical company said Thursday that the Food and ...

The first participant in an investigational gene therapy trial of STXBP1 encephalopathy died, Capsida Biotherapeutics said.

It’s now possible to treat inherited blood diseases, such as sickle cell disease, with gene editing. Blood stem cells are extracted from the patient, modified, and infused back into their bone ...

Backed by NIH, DNA Nanobots aims to disrupt gene therapy with scalable, non-viral platform—$5M round now open to select investors. We're at a pivotal moment, with platform validation and NIH support, ...

Research focused on long-acting therapeutics based on Remedium's proprietary Prometheus™ platform· Multiple targets for the treatment of Obesity and Type 2 Diabetes BOSTON, MASSACHUSETTS / ACCESS ...

At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of ...